Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Transdermal drug delivery preparation with drug-loaded three-dimensional mesh spatial configuration and preparation method of transdermal drug delivery preparation

A three-dimensional network and three-dimensional configuration technology, which is applied in the direction of pharmaceutical formulations, medical preparations of non-active ingredients, sheet delivery, etc., can solve the problems of poor patient compliance, poor drug stability, and unsatisfactory adhesion performance of pressure-sensitive adhesive systems, etc. question

Inactive Publication Date: 2015-06-03
SHANGHAI MODERN PHARMA ENG INVESTIGATION CENT
View PDF7 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] Oxybutynin is rapidly metabolized by the liver when taken orally, with a bioavailability of only 6%, and it is accompanied by side effects such as dry mouth, astringent mouth, constipation, and blurred vision. Therefore, patients’ compliance is poor
[0005] At present, the carriers of conventional transdermal drug delivery preparations, such as the pressure-sensitive adhesive matrix transdermal drug delivery systems disclosed in patents CN1269717A and CN101229144A, all have low drug loading, easy crystallization of drugs, and influence on transdermal absorption performance. The adhesive performance of the pressure-sensitive adhesive system is not ideal, the pressure-sensitive adhesive system is easy to age, and the drug stability is poor, which is difficult to meet the clinical needs.
Chinese patent CN1134254C discloses a plaster-type transdermal preparation containing oxybutynin based on an ammonium-containing acrylate or methacrylate copolymer. The area is large, the skin tolerance is poor, and the drug is easy to precipitate in the pressure-sensitive adhesive; Chinese patent CN101455650A discloses an oxybutynin hydrochloride patch that also uses a hydrophobic pressure-sensitive adhesive as a matrix, but it needs a small amount of water to dissolve Drugs, poor compatibility with hydrophobic pressure-sensitive adhesive matrix, difficult to mix evenly

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Transdermal drug delivery preparation with drug-loaded three-dimensional mesh spatial configuration and preparation method of transdermal drug delivery preparation
  • Transdermal drug delivery preparation with drug-loaded three-dimensional mesh spatial configuration and preparation method of transdermal drug delivery preparation
  • Transdermal drug delivery preparation with drug-loaded three-dimensional mesh spatial configuration and preparation method of transdermal drug delivery preparation

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1-10

[0064] See Table 1 for the drug-loaded three-dimensional net-like three-dimensional configuration of the transdermal drug delivery controlled release system.

[0065] Table 1

[0066]

[0067]

Embodiment 11-20

[0069] See Table 2 for the transdermal drug delivery system in the three-dimensional network configuration used for drug loading.

[0070] Table 2

[0071]

[0072] Table 2 (continued, see the previous table for the types and amounts of adhesives and skin penetration enhancers in each embodiment).

[0073]

Embodiment 21~30

[0075] The drug-loaded three-dimensional network three-dimensional configuration of the transdermal drug delivery system, see Table 3

[0076] table 3

[0077]

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Apertureaaaaaaaaaa
Apertureaaaaaaaaaa
Particle sizeaaaaaaaaaa
Login to View More

Abstract

The invention discloses a transdermal drug delivery preparation with a drug-loaded three-dimensional mesh spatial configuration and a preparation method of the transdermal drug delivery preparation. The transdermal drug delivery preparation with the drug-loaded three-dimensional mesh spatial configuration is composed of a transdermal drug delivery with the drug-loaded three-dimensional mesh spatial configuration, a backing layer and an anti-sticking layer, wherein the backing layer is compounded on one side of the transdermal drug delivery with the drug-loaded three-dimensional mesh spatial configuration; the anti-sticking layer is compounded on the other side of the transdermal drug delivery with the drug-loaded three-dimensional mesh spatial configuration; and an active medicine comprises the forms of oxybutynin hydrochloride or tartrate thereof, sulfate, phosphate, fumarate and a basic group. According to the transdermal drug delivery preparation, the drug loading capacity is greatly increased; the drug loading capacity can be improved; the medicine devitrification is inhibited; the medicines are sequentially and uniformly dispersed into the transdermal drug delivery system; stable release is carried out; long-term lasting transdermal permeation of the medicines can be realized; stable blood concentration is maintained; and the preparation is high in transdermal absorption rate and high in transdermal absorption amount, and has the characteristics of being stable and efficient.

Description

technical field [0001] The invention relates to a three-dimensional network three-dimensional transdermal drug delivery system containing oxybutynin with nanoporous silicon dioxide as a carrier and a preparation method thereof. Background technique [0002] Transdermal drug delivery preparation is a sustained and controlled release preparation in which the active drug is absorbed into the blood circulation of the whole body through the skin and has a therapeutic effect. The transdermal drug delivery preparation is composed of an active ingredient and a carrier. In addition to the performance of the ingredients, it is mainly determined by the carrier used to load the active ingredients. [0003] Active drugs for the treatment of overactive bladder, such as oxybutynin hydrochloride and its base form, as the third-generation drug of choice for urinary incontinence in the treatment of overactive bladder, have both anticholinergic and anti-smooth muscle spasm effects, and are sui...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K9/70A61K47/04A61K31/216A61P13/10A61P13/00
Inventor 罗华菲王浩候惠民武余波陈纯
Owner SHANGHAI MODERN PHARMA ENG INVESTIGATION CENT
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products